The Area Prescribing Committee recommends avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure in line with NICE guidance (NICE TA 626)
Avatrombopag is a payment by results excluded medicine and will be considered RED on the traffic light system. Prescribers will be required to complete a blueteq form at initiation
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication
